Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation

被引：0
|
作者：
Gupta, Aarti [1 ]
Kumar, Lalit [1 ]
机构：
[1] All India Inst Med Sci, Inst Rotary Canc Hosp, Dept Med Oncol, New Delhi 110029, India
来源：
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY | 2008年 / 29卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：49 / 52
页数：4
相关论文
共 50 条
  • [41] Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis
    Lee, S. Y.
    Meehan, R. S.
    Seldin, D. C.
    Sloan, J. M.
    Quillen, K.
    Shelton, A.
    Brauneis, D.
    Sanchorawala, V.
    BONE MARROW TRANSPLANTATION, 2016, 51 (10) : 1318 - 1322
  • [42] High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators
    Phull, Pooja
    Sanchorawala, Vaishali
    Brauneis, Dina
    Sloan, J. Mark
    Siddiqi, Omar K.
    Quillen, Karen
    Sarosiek, Shayna
    BONE MARROW TRANSPLANTATION, 2019, 54 (08) : 1304 - 1309
  • [43] Melphalan and high-dose dexamethasone in patients with AL (primary) amyloidosis ineligible for autologous stem cell transplantation.
    Palladini, G
    Perfetti, V
    Obici, L
    Merlini, G
    BLOOD, 2002, 100 (11) : 397A - 398A
  • [44] Pulsed low dose intravenous melphalan in patients with AL amyloidosis, ineligible for aggressive treatment with high-dose melphalan and stem cell transplantation.
    Sanchorawala, V
    Seldin, DC
    Wright, DG
    Skinner, M
    Finn, KT
    Falk, RH
    BLOOD, 2004, 104 (11) : 657A - 658A
  • [45] Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis
    Shayna Sarosiek
    Luke Zheng
    J. Mark Sloan
    Karen Quillen
    Dina Brauneis
    Vaishali Sanchorawala
    Blood Cancer Journal, 10
  • [46] Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis
    Sarosiek, Shayna
    Zheng, Luke
    Sloan, J. Mark
    Quillen, Karen
    Brauneis, Dina
    Sanchorawala, Vaishali
    BLOOD CANCER JOURNAL, 2020, 10 (08)
  • [47] High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study
    Skinner, M
    Sanchorawala, V
    Seldin, DC
    Dember, LM
    Falk, RH
    Berk, JL
    Anderson, JJ
    O'Hara, C
    Finn, KT
    Libbey, CA
    Wiesman, J
    Quillen, K
    Swan, N
    Wright, DG
    ANNALS OF INTERNAL MEDICINE, 2004, 140 (02) : 85 - 93
  • [48] Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65
    Seldin, David C.
    Anderson, Jennifer J.
    Skinner, Martha
    Malek, Karim
    Wright, Daniel G.
    Quillen, Karen
    Finn, Kathleen
    Oran, Betul
    Sanchorawala, Vaishali
    BLOOD, 2006, 108 (12) : 3945 - 3947
  • [49] High-dose melphalan with CD34+blood stem cell transplantation in patients with AL amyloidosis: a feasible approach
    Akpek, G
    Vosburgh, E
    Michelle, D
    LaBlanc, M
    Fisher, C
    Zhang, Y
    Wally, J
    Kica, G
    Skinner, M
    Falk, R
    Dember, LM
    Finn, K
    Sanchorawala, V
    Comenzo, RL
    AMYLOID AND AMYLOIDOSIS 1998, 1999, : 175 - 177
  • [50] Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease
    Girnius, Saulius
    Seldin, David C.
    Skinner, Martha
    Finn, Kathleen T.
    Quillen, Karen
    Doros, Gheorghe
    Sanchorawala, Vaishali
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (07): : 1029 - 1032
12345